Evaluation of Preoperative Investigations in Patients With Liver Cancer
NCT ID: NCT00408122
Last Updated: 2014-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2007-01-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging
NCT01522209
Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study
NCT03444194
Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases
NCT00242086
EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer
NCT02209415
Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Cancer
NCT01544452
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PET/CT scan and EUS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients who are not fit for liver surgery because of co-morbidity
* patients for whom the extra investigations in the study are considered to give an increased risk because of co-morbidity such as
* Patients with s-creatinin \> 150 micromol/l
* Patients who take peroral antidiabetic drugs or have a poorly regulated diabetes mellitus
* patients who do not understand the patient information
* patients who do not want to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alan Patrick Ainsworth
dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henning O Nielsen, MD, DMsc
Role: PRINCIPAL_INVESTIGATOR
dept. of Surgery, Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Surgery, Odense university Hospital
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VF-20060109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.